title: Is the lower mortality in patients treated with aspirin and angiotensin-converting enzyme inhibitors due to decreased norepinephrine release?
authors.forename: R
authors.initials: R
authors.lastname: Levi
authors.forename: R
authors.initials: R
authors.lastname: Maruyama
authors.forename: N C
authors.initials: NC
authors.lastname: Smith
authors.forename: N
authors.initials: N
authors.lastname: Seyedi
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D003327:Coronary Disease / Q000097:blood / Q000188:drug therapy / Q000401:mortality*; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006333:Heart Failure / Q000097:blood / Q000188:drug therapy / Q000401:mortality*; D006801:Humans; D009638:Norepinephrine / Q000097:blood*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D012307:Risk Factors; D015996:Survival Rate
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D015415:Biomarkers; D010975:Platelet Aggregation Inhibitors; D001241:Aspirin; D009638:Norepinephrine